Poniard Pharmaceuticals, Inc. (PARD)

[rodneys]

They invested more than 100 million and they have a few results:

Poniard Pharmaceuticals Announces Updated Positive Clinical Data from Phase 2 Trial of Picoplatin in Colorectal Cancer and New Phase 1 Cardiac Safety Trial Results

Poniard Pharmaceuticals, Inc. (PARD) has received Clinical Trial Application (CTA) approval from the Chinese State Food and Drug Administration (SFDA) to conduct two Phase III clinical studies of its lead product candidate, picoplatin, in the treatment of second-line small cell lung cancer (SCLC) and second-line ovarian cancer in the People's Republic of China.

VSTM paid Poniard an upfront license fee and agreed to pay Poniard milestone payments of up to an aggregate of $13,250,000 upon the achievement of specified development and regulatory milestones.

And yes it’s gambling you do !! I own 13.500 shares av. 1.09. and hope to sell them for at least 1.50.